Archives

by in
Entry Author Date Location
Biogen Idec Wins FDA Approval For Oral Multiple Sclerosis Drug 03/27/13 Boston
Build Credibility As You Build Your Business 03/26/13 Seattle
Q&A With Bob Tepper on What’s Next for Third Rock Ventures 03/26/13 Boston
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
Cerulean Pharma Fails to Extend Lives in Lung Cancer Study 03/22/13 Boston
San Diego Life Sciences Roundup: Health IT, Illumina, & More 03/22/13 San Diego
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
Pyxis Founder Ron Taylor Joins Connect Entrepreneur Hall of Fame 03/21/13 San Diego
Study Says Medical Device Interoperability Could Save $30B a Year 03/21/13 San Diego
Memorial Sloan-Kettering and Eureka Go After ‘Undruggable’ Targets 03/21/13 New York
Drug Development: Let’s Play! 03/21/13 Seattle
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
UCSD Business School’s Venture Fund Joins Texas Startup’s $16M Deal 03/20/13 San Diego
Blueprint Medicines Combs Through Genome for the Next Gleevec(s) 03/20/13 Boston
Fighting a Global War on Rare Diseases 03/20/13 New York
Why Are Healthcare Costs Exploding? See Proton Cancer Therapy 03/18/13 National
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
San Diego Life Sciences Roundup: Ambit, Lithera, Histogen, & More 03/14/13 San Diego
Has The Pendulum Swung Too Far in Favor of Rare Diseases? 03/14/13 Seattle
New Domain Partnership Focuses on China’s Emerging Healthcare Market 03/13/13 San Diego
Pfizer Yields to Rivals in Hep C Drug Race 03/13/13 New York
Ambit Still Committed to Leukemia Drug After Astellas Ends Pact 03/12/13 San Diego
GlaxoSmithKline Shuts Down Sirtris, Five Years After $720M Buyout 03/12/13 Boston
Four Things I Learned From Studying Innovation in 3 U.S. Cities 03/12/13 San Diego
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
San Diego Life Sciences Roundup: Life Technologies, Althea, Sorrento 03/08/13 San Diego
Roger Perlmutter Returns to Merck, Looks to Biotech Future (Again) 03/07/13 New York
Cerulean Pharma Arrives at Turning Point With Cancer Drug 03/06/13 Boston
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Synteract Acquires Harrison Clinical Research to Form Global CRO 03/04/13 San Diego
Page 3 of 66 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.